lung cancer

Showing 6 posts of 186 posts found.

Antisoma cancer drug fails in phase III

March 29, 2010
Research and Development Antisoma, NSCLC, lung cancer

UK biotech Antisoma has suffered a disappointing late-stage failure with a potential lung cancer treatment it was developing with Novartis. …

Tarceva gets nod for maintenance treatment

March 22, 2010
Sales and Marketing Tarceva, lung cancer

Tarceva looks set to gain approval in Europe to treat patients with non-small cell lung cancer whose disease remains stable …

Novartis buys into Transgene’s lung cancer candidate

March 11, 2010
Research and Development Novartis, Transgene, immunotherapy, lung cancer

French biotech company Transgene has signed a deal with Novartis for the future development and marketing of its potential lung …

lung cancer

New approaches in lung cancer

January 1, 2010
Sales and Marketing lung cancer

Lung cancer is the most common cancer in the world, with 1.3 million new cases diagnosed every year. The vast …

Avastin approved as first-line treatment for lung cancer

August 24, 2007
Sales and Marketing avastin, lung cancer

Roche's cancer drug Avastin has gained European approval as a first-line treatment for lung cancer on the back of data …

NICE judges Tarceva too expensive for NHS

March 9, 2007
Sales and Marketing Tarceva, lung cancer

Roche's cancer drug Tarceva has been rejected by NICE for use against the most common form of lung cancer.The watchdog …

Latest content